It's a Trap! CDK8 Inhibition Reveals a Shared Vulnerability through Mediator Trapping in Fusion-Driven Pediatric Sarcomas.

CDK8 inhibition is a shared therapeutic vulnerability in pediatric fusion oncoprotein-driven sarcomas, disrupting oncogenic transcription via Mediator complex trapping on chromatin.

• Why it matters: Neomorphic transcription factors in pediatric sarcomas are difficult to target, leaving a gap for therapies that can reliably shut down their transcriptional programs.
• What they did: Two independent studies tested CDK8 inhibitors and found they interfere with oncogenic transcription through a gain-of-function mechanism that traps the Mediator complex on chromatin.
• The result: These findings suggest CDK8 inhibitors can therapeutically disrupt fusion-driven transcriptional programs in pediatric sarcoma models by exploiting Mediator trapping.

AI summary of the abstract · may contain errors · not medical advice · read the paper.